NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human tests begin for potential new netherton syndrome treatment
Disease control Recruiting nowThis is an early-stage study to first test the safety of a new drug called BCX17725 in healthy volunteers. It will then test multiple doses in people with Netherton syndrome, a rare genetic skin condition, to see how the body handles the drug and if it helps reduce skin redness, …
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First-of-its-Kind skin ointment aims to treat rare genetic disease at its source
Disease control Recruiting nowThis is the first human study to test a new topical ointment, ATR12-351, designed to treat the underlying cause of Netherton Syndrome. The trial will enroll about 12 adults to check if the ointment is safe and well-tolerated when applied to skin lesions twice daily for two weeks.…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC